These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 21638278

  • 1. Outcomes after adjuvant chemotherapy in the treatment of high-risk urothelial carcinoma of the upper urinary tract (UUT-UC): results from a large multicenter collaborative study.
    Vassilakopoulou M, de la Motte Rouge T, Colin P, Ouzzane A, Khayat D, Dimopoulos MA, Papadimitriou CA, Bamias A, Pignot G, Nouhaud FX, Hurel S, Guy L, Bigot P, Roumiguié M, Rouprêt M, French Collaborative National Database on UUT-UCC.
    Cancer; 2011 Dec 15; 117(24):5500-8. PubMed ID: 21638278
    [Abstract] [Full Text] [Related]

  • 2. Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.
    Hellenthal NJ, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Bolenz C, Remzi M, Weizer A, Zigeuner R, Bensalah K, Ng CK, Raman JD, Kikuchi E, Montorsi F, Oya M, Wood CG, Fernandez M, Evans CP, Koppie TM.
    J Urol; 2009 Sep 15; 182(3):900-6. PubMed ID: 19616245
    [Abstract] [Full Text] [Related]

  • 3. Comparison of oncological outcomes after segmental ureterectomy or radical nephroureterectomy in urothelial carcinomas of the upper urinary tract: results from a large French multicentre study.
    Colin P, Ouzzane A, Pignot G, Ravier E, Crouzet S, Ariane MM, Audouin M, Neuzillet Y, Albouy B, Hurel S, Saint F, Guillotreau J, Guy L, Bigot P, De La Taille A, Arroua F, Marchand C, Matte A, Fais PO, Rouprêt M, French Collaborative National Database on U.U.T.-U.C.
    BJU Int; 2012 Oct 15; 110(8):1134-41. PubMed ID: 22394612
    [Abstract] [Full Text] [Related]

  • 4. Bladder cancer after nephroureterectomy in patients with urothelial carcinoma of the upper urinary tract.
    Ku JH, Choi WS, Kwak C, Kim HH.
    Urol Oncol; 2011 Oct 15; 29(4):383-7. PubMed ID: 19556154
    [Abstract] [Full Text] [Related]

  • 5. Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.
    Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.
    Urol Int; 2012 Oct 15; 88(2):225-31. PubMed ID: 22236640
    [Abstract] [Full Text] [Related]

  • 6. The role of chemotherapy in the treatment of urothelial cell carcinoma of the upper urinary tract (UUT-UCC).
    Audenet F, Yates DR, Cussenot O, Rouprêt M.
    Urol Oncol; 2013 May 15; 31(4):407-13. PubMed ID: 20884249
    [Abstract] [Full Text] [Related]

  • 7. The role of American Society of Anesthesiologists scores in predicting urothelial carcinoma of the upper urinary tract outcome after radical nephroureterectomy: results from a national multi-institutional collaborative study.
    Berod AA, Colin P, Yates DR, Ouzzane A, Audouin M, Adam E, Arroua F, Marchand C, Bigot P, Soulié M, Roumiguié M, Polguer T, Gardic S, Grès P, Ravier E, Neuzillet Y, Delage F, Bodin T, Pignot G, Rouprêt M, French National Database of UUT UC.
    BJU Int; 2012 Dec 15; 110(11 Pt C):E1035-40. PubMed ID: 22568669
    [Abstract] [Full Text] [Related]

  • 8. Adjuvant methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy has potential to prevent recurrence of bladder tumors after surgical removal of upper urinary tract transitional cell carcinoma.
    Soga N, Arima K, Sugimura Y.
    Int J Urol; 2008 Sep 15; 15(9):800-3. PubMed ID: 18651862
    [Abstract] [Full Text] [Related]

  • 9. Antegrade perfusion with bacillus Calmette-Guérin in patients with non-muscle-invasive urothelial carcinoma of the upper urinary tract: who may benefit?
    Giannarini G, Kessler TM, Birkhäuser FD, Thalmann GN, Studer UE.
    Eur Urol; 2011 Nov 15; 60(5):955-60. PubMed ID: 21807456
    [Abstract] [Full Text] [Related]

  • 10. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct 15; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 11. Assessment of oncologic control obtained after open versus laparoscopic nephroureterectomy for upper urinary tract urothelial carcinomas (UUT-UCs): results from a large French multicenter collaborative study.
    Ariane MM, Colin P, Ouzzane A, Pignot G, Audouin M, Cornu JN, Albouy B, Guillotreau J, Neuzillet Y, Crouzet S, Hurel S, Arroua F, Bigot P, Marchand C, Fais PO, de la Taille A, Saint F, Ravier E, Matte A, Guy L, Bruyère F, Rouprêt M.
    Ann Surg Oncol; 2012 Jan 15; 19(1):301-8. PubMed ID: 21691878
    [Abstract] [Full Text] [Related]

  • 12. Outcome of surgical treatment of patients with upper versus lower urinary tract urothelial carcinoma: stage-by-stage comparison.
    Moussa S, Yafi FA, El-Hakim A, Fahmy N, Aprikian A, Tanguay S, Anidjar M, Kassouf W.
    Urol Int; 2010 Jan 15; 84(1):50-5. PubMed ID: 20173369
    [Abstract] [Full Text] [Related]

  • 13. Lymphovascular invasion is independently associated with poor prognosis in patients with localized upper urinary tract urothelial carcinoma treated surgically.
    Saito K, Kawakami S, Fujii Y, Sakura M, Masuda H, Kihara K.
    J Urol; 2007 Dec 15; 178(6):2291-6; discussion 2296. PubMed ID: 17936818
    [Abstract] [Full Text] [Related]

  • 14. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cN0M0).
    Lin WC, Hu FC, Chung SD, Chueh SC, Pu YS, Huang KH.
    J Urol; 2008 Sep 15; 180(3):879-84; discussion 884-5. PubMed ID: 18635224
    [Abstract] [Full Text] [Related]

  • 15. Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup.
    Sanderson KM, Cai J, Miranda G, Skinner DG, Stein JP.
    J Urol; 2007 Jun 15; 177(6):2088-94. PubMed ID: 17509294
    [Abstract] [Full Text] [Related]

  • 16. [Prognosis in pT3b infiltrating tumors of the bladder treated by adjuvant chemotherapy].
    Sahwi A, Robert M, Delbos O, Legouffe E, Guiter J, Navratil H.
    Prog Urol; 1998 Dec 15; 8(6):1007-11. PubMed ID: 9894259
    [Abstract] [Full Text] [Related]

  • 17. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD, Sosa RE, Vaughan ED, Scherr DS.
    Urology; 2007 Feb 15; 69(2):251-4. PubMed ID: 17320658
    [Abstract] [Full Text] [Related]

  • 18. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool.
    Audenet F, Colin P, Yates DR, Ouzzane A, Pignot G, Long JA, Soulie M, Phé V, Bensadoun H, Guy L, Ruffion A, Valeri A, Cormier L, Droupy S, de La Taille A, Saint F, Faïs PO, Houlgatte A, Cussenot O, Rouprêt M, French Collaborative National Database on UUT-UC.
    BJU Int; 2012 Dec 15; 110(11 Pt B):E583-9. PubMed ID: 22703159
    [Abstract] [Full Text] [Related]

  • 19. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun 15; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 20. Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer.
    Suzuki S, Shinohara N, Harabayashi T, Sato S, Abe T, Koyanagi T.
    Int J Urol; 2004 Jul 15; 11(7):456-60. PubMed ID: 15242352
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.